Macitentan (OPSUMIT)

Endothelin receptor antagonist

Macitentan (OPSUMIT)

Forms and strengths
Form: TabletStrength: 10 mg film-coated tablet; 2.5 mg dispersible tablet
Print

Indication

  • Macitentan is used for the long-term treatment of pulmonary arterial hypertension (WHO Group I) to reduce disease-related complications in adults with WHO Functional Class II or III disease that is idiopathic, heritable, or associated with connective tissue disease or congenital heart disease.
  • Macitentan is used for the same indication in pediatric patients aged 2 to less than 18 years.
  • Macitentan is effective when used alone or in combination with a phosphodiesterase-5 inhibitor such as sildenafil.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.